Search Results - "LaRosée, Paul"

The soluble transferrin receptor reflects tumor load in chronic lymphocytic leukemia by Metzgeroth, Georgia, Schultheis, Beate, Kuhn, Christian, Dorn-Beineke, Alexandra, LaRosée, Paul, Hehlmann, Rüdiger, Hastka, Jan

“…The soluble transferrin receptor (sTfR) is a parameter of erythropoietic activity and iron deficiency. Increased levels have also been described in…”
Get more information

Regulation of protein kinase C isozymes in volume overload cardiac hypertrophy by Braun, Martin U, LaRosée, Paul, Simonis, Gregor, Borst, Mathias M, Strasser, Ruth H

“…Protein kinase C (PKC) is a family of at least 11 isozymes and known to play a crucial role in myocardial growth. The present study was performed to…”
Get full text

Tyrosinekinase inhibition facilitates cooperation of transcription factor SALL4 and ABC transporter A3 towards intrinsic CML cell drug resistance by Hupfeld, Timo, Chapuy, Bjoern, Schrader, Verena, Beutler, Markus, Veltkamp, Christian, Koch, Raphael, Cameron, Silke, Aung, Thiha, Haase, Detlef, LaRosee, Paul, Truemper, Lorenz, Wulf, Gerald G.

“…Summary Although BCR‐ABL1 tyrosine kinase inhibitors reliably induce disease remission for patients with chronic myeloid leukaemia (CML), unlimited extension…”
Get full text

Differential regulation of cardiac protein kinase C isozyme expression after aortic banding in rat by BRAUN, Martin U, LAROSEE, Paul, SCHÖN, Steffen, BORST, Mathias M, STRASSER, Ruth H

“…Protein kinase C (PKC) plays a key role in myocardial hypertrophy. To evaluate whether its isoforms are expressed differentially during gradual development of…”
Get full text

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas – a Randomized Controlled Trial Comparing Different Treatment Approaches Based on Interim PET Results (PETAL Trial) by Duehrsen, Ulrich, Hüttmann, Andreas, Müller, Stefan, Hertenstein, Bernd, Kotzerke, Jörg, Mesters, Rolf, Franzius, Christiane, Kroschinsky, Frank, Weckesser, Matthias, Franzke, Anke, Bengel, Frank, Dürig, Jan, Matschke, Johannes, Pöppel, Thorsten, Rekowski, Jan, Ose, Claudia, Brinkmann, Marcus, LaRosée, Paul, Freesmeyer, Martin, Hertel, Andreas, Hoeffkes, Heinz-Gert, Behringer, Dirk, Prange-Krex, Gabriele, Wilop, Stefan, Krohn, Thomas, Fricke, Eva, Griesshammer, Martin, Giagounidis, Aristoteles, Raghavachar, Aruna, Maschmeyer, Georg, Brink, Ingo, Brecht, Arne, Haberkorn, Uwe, Gaska, Tobias, Klapper, Wolfram, Hoelzer, Dieter, Jöckel, Karl-Heinz, Scherag, André, Bockisch, Andreas

“…Introduction: The predictive value of 18-fluorodeoxyglucose PET performed after a few cycles of chemotherapy has been questioned in aggressive lymphomas…”
Get full text

Desensitization of the pulmonary adenylyl cyclase system : A cause of airway hyperresponsiveness in congestive heart failure? by BORST, M. M, BEUTHIEN, W, SCHWENCKE, C, LAROSEE, P, MARQUETANT, R, HAASS, M, KÜBLER, W, STRASSER, R. H

“…This study was designed to investigate whether the adrenergic signal transduction in the lung and the responsiveness of airway smooth muscle to adrenergic…”
Get full text

Temsirolimus in Combination with Bendamustine and Rituximab (BeRT) for the Treatment of Relapsed Mantle Cell and Follicular Lymphoma: Final Phase I/II Results by Hess, Georg, Karola, Wagner, LaRosee, Paul, Keller, Ulrich, Atta, Johannes, Witzens-Harig, Mathias, Crombé, Anne, Medler, Christoph, Borchmann, Peter, Bitz, Ulrich, Lerchenmüller, Christian, Theobald, Matthias, Dreyling, Martin H.

“…Background: mTOR inhibition has been shown to be effective in various subtypes of malignant lymphomas (Smith et al, JCO 2010). Furthermore, in relapsed MCL a…”
Get full text

Temsirolimus in Combination with Bendamustine and Rituximab for the Treatment of Relapsed Mantle Cell and Follicular Lymphoma: Report on an Ongoing Phase I/II Trial by Hess, Georg, Keller, Ulrich, Atta, Johannes, Bitz, Ulrich, Lerchenmueller, Christian, Karola, Wagner, Medler, Christoph, Ruckes, Christian, Witzens-Harig, Mathias, Huebel, Kai, LaRosee, Paul, Dreyling, Martin H.

“…Background: mTOR inhibition has been shown to be effective in various subtypes of malignant lymphomas. In relapsed MCL a phase III trial could prove…”
Get full text

Safety and Clinical Activity of Temsirolimus in Combination with Rituximab and DHAP in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma - Report of the Prospective, Multicenter Phase II STORM Trial by Witzens-Harig, Mathias, Viardot, Andreas, Keller, Ulrich, Buske, Christian, Crombé, Anne, Hoenig, Elisabeth, Atta, Johannes, Schmier, Johann, Meissner, Julia, Ho, Anthony D., LaRosee, Paul, Marks, Reinhard, Dreyling, Martin, Hess, Georg

“…Purpose. To evaluate the safety, tolerability and efficacy of the combination of the mTOR inhibitor Temsirolimus and a standard salvage regimen (R-DHAP) in…”
Get full text

Tyrosinekinase inhibition facilitates cooperation of transcription factor SALL 4 and ABC transporter A3 towards intrinsic CML cell drug resistance by Hupfeld, Timo, Chapuy, Bjoern, Schrader, Verena, Beutler, Markus, Veltkamp, Christian, Koch, Raphael, Cameron, Silke, Aung, Thiha, Haase, Detlef, LaRosee, Paul, Truemper, Lorenz, Wulf, Gerald G.

“…Although BCR ‐ ABL 1 tyrosine kinase inhibitors reliably induce disease remission for patients with chronic myeloid leukaemia ( CML ), unlimited extension of…”
Get full text

Desensitization of the pulmonary adenylyl cyclase system by Borst, Mathias M, Beuthien, Wilke, Schwencke, Carsten, LaRosée, Paul, Marquetant, Rainer, Haass, Markus, Kübler, Wolfgang, Strasser, Ruth H

“…OBJECTIVES This study was designed to investigate whether the adrenergic signal transduction in the lung and the responsiveness of airway smooth muscle to…”
Get full text